Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safeguarding America's Pharmaceuticals Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
Safeguarding America's Pharmaceuticals Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2013 · third_quarter · Q3
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
Source: Senate LDA
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2014
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.2725 FDA Safety Over Sequestration Act of 2013; S.1244 FY14 FDA Appropriations bill relating to sequestered user fees; S.1413 FDA User Fee Protection Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
Pharmaceutical Quality, Security, and Accountability Act
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.3204 The Compounding Clarity Act; S.959 The Pharmaceutical Quality, Security and Accountability Act
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
H.R.933 Consolidated and Further Continuing Appropriations Act relating to FDA biosimilar user fees; S.Con. Res.8 - provisions relating to ACA medical device tax.
Safeguarding America's Pharmaceuticals Act of 2011
Client: HOSPIRA INC · Firm: HOSPIRA, INC.
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
H.R.8 American Taxpayer Relief Act of 2012 (Fiscal Cliff); Medical device tax delay
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
H.R.1919 Safeguarding America's Pharmaceuticals Act of 2013; H.R.3204 The Drug Quality and Safety Act; Issues relating to prescription drug shortages; P.L. 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products; S.232 Medical Device Access and Innovation Protection Act; S.957 The Drug Supply Chain of Security Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Q2
HR. 1919 - Safeguarding America's Pharmaceuticals Act of 2013. P.L. 111-148 - Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. S. 957 and S. 959 - The Drug Supply Chain of Security Act. Issues relating to generic drug labeling.
S.1244 - FY14 FDA Appropriations bill relating to sequestered user fees.
H.R. 486 - relating to the compounding of drug products House Discussion Draft amending 503A of FFDCA with respect to pharmacy compounding S. 959 Compounding and Pedigree bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · first_quarter · Q1
PL 111-148 Patient Protection and Affordable Health Care Act provisions relating to biosimilar products. Issues relateing to generic drug labeling and drug pedigree.
H.R.933 Consolidated and Further Continuing Appropriations Act relating to FDA biosimilar user fees; S.Con. Res.8 - provisions relating to ACA medical device tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · fourth_quarter · Q4
S.2295 Patient Safety and Generic Labeling Improvement Act; Senate Draft Proposal to Improve Drug Distribution Security
IP
H.R.8 American Taxpayer Relief Act of 2012 (Fiscal Cliff); Medical device tax delay
Trade
H.J.Res.117 Continuing Appropriations Resolution, 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · third_quarter · Q3
IP
Trade
Drug Pedigree; Drug Shortages; Generic Drug Labeling; Generic Drugs; HR3026 Safeguarding America's Pharmaceutical Act of 2011; HR4223 Safe Doses Act; S1002 Safe Doses Act; HR5651 FDA Reform Act of 2012; S3187 FDA Safety and Innovation Act; HR6433 FDA User Fee Corrections Act of 2012; HR3590 Patient Protection and Affordable Health Care Act provisions relating to biosimilar medicines; S2295 Patient Safety and Generic Labeling Improvement Act
H.J.Res.117 Continuing Appropriations Resolution, 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2012 · second_quarter · Q2
Drug Shortages; Generic Drug Labeling; Generic Drugs; H.R.5651 Food and Drug Administration Reform Act of 2012; S.3187 Food and Drug Administration Safety and Innovation Act
Trade
IP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)